↓ Skip to main content

Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia

Overview of attention for article published in Cochrane database of systematic reviews, January 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

blogs
2 blogs
twitter
84 tweeters
facebook
3 Facebook pages
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
249 Dimensions

Readers on

mendeley
360 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia
Published in
Cochrane database of systematic reviews, January 2014
DOI 10.1002/14651858.cd007115.pub3
Pubmed ID
Authors

Michael PT Lunn, Richard AC Hughes, Philip J Wiffen

Abstract

Duloxetine is a balanced serotonin and noradrenaline reuptake inhibitor licensed for the treatment of major depressive disorders, urinary stress incontinence and the management of neuropathic pain associated with diabetic peripheral neuropathy. A number of trials have been conducted to investigate the use of duloxetine in neuropathic and nociceptive painful conditions. This is the first update of a review first published in 2010.

Twitter Demographics

The data shown below were collected from the profiles of 84 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 360 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 <1%
Canada 1 <1%
Switzerland 1 <1%
Brazil 1 <1%
Denmark 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 351 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 63 18%
Student > Bachelor 52 14%
Researcher 49 14%
Student > Ph. D. Student 36 10%
Student > Postgraduate 34 9%
Other 96 27%
Unknown 30 8%
Readers by discipline Count As %
Medicine and Dentistry 171 48%
Nursing and Health Professions 37 10%
Pharmacology, Toxicology and Pharmaceutical Science 25 7%
Psychology 19 5%
Agricultural and Biological Sciences 15 4%
Other 45 13%
Unknown 48 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 72. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 August 2019.
All research outputs
#260,686
of 14,308,102 outputs
Outputs from Cochrane database of systematic reviews
#643
of 10,947 outputs
Outputs of similar age
#4,530
of 258,127 outputs
Outputs of similar age from Cochrane database of systematic reviews
#10
of 162 outputs
Altmetric has tracked 14,308,102 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,947 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.7. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 258,127 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 162 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.